Suggestions
Stephen Moran
Going nuclear on cancer at Novartis
Stephen Moran is a senior executive at Novartis, holding the position of Global Program Head & Platform Lead for Radiopharmaceuticals.1 He has a strong background in the pharmaceutical industry and is based in Switzerland.1
Professional Experience
Stephen's current role at Novartis involves leading the company's radiopharmaceutical platform. In this capacity, he recently announced an exciting collaboration between Novartis and PeptiDream, aimed at strengthening Novartis' radiopharmaceutical platform.2 This partnership, announced on May 2, 2024, has a potential value of $2.7 billion, highlighting the significance of Stephen's work in this field.2
Education and Background
Stephen Moran's educational background includes studying at the University of Cambridge, which likely contributed to his expertise in the pharmaceutical and radiopharmaceutical sectors.1
Professional Network
As a testament to his standing in the industry, Stephen has over 500 connections on LinkedIn, indicating a robust professional network.1 His LinkedIn profile (username: stephenmoran3) serves as a platform for sharing updates about his work and Novartis' initiatives in the radiopharmaceutical space.
Stephen Moran's role at Novartis and his involvement in significant collaborations suggest that he is a key figure in the development and advancement of radiopharmaceutical technologies within the company.
